| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.58 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.098 | 0.04 |